9 Hrs
Source:
Le Monde
Le Monde
Ready to play
Ready to play
The investigation examines how the company marketed Efluelda, an enhanced flu vaccine intended for people over 60, focusing on its promotion and claims of greater protection.
Notice: This Is an AI-Generated Summary
Comments (0)